Sponsor:
Mayo Clinic
Code:
NCT06797193
Conditions
Portal Hypertension
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Electronic Health Record Review
Liver Biopsy
Medical Device Usage and Evaluation
Perflutren Lipid Microspheres
Ultrasound Imaging
Brief summary:
Conditions
Portal Hypertension
Study ID
NCT06797193
Start date
Mar 13, 2025
Status verified date
Aug, 2026
Completion date
Mar 31, 2027
Anticipated
Primary completion date
Mar 31, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Diagnostic (Definity, SHAPE)
Interventions
Electronic Health Record Review
Liver Biopsy
Medical Device Usage and Evaluation
Perflutren Lipid Microspheres
Ultrasound Imaging
Primary outcome measure
Central contacts
Bea Hartke
507-284-9653Locations
Mayo Clinic in Arizona
Recruiting
Scottsdale, Arizona, United States, 85259
Contacts
Nirvi Dahiya, MD
Dahiya.Nirvi@mayo.eduAubrey Smith
480-301-6104Principal Investigator:
Nirvi Dahiya, MD
Mayo Clinic in Florida
Recruiting
Jacksonville, Florida, United States, 32224-9980
Contacts
Melanie Caserta, MD
caserta.melanie@mayo.eduRobert P. Jones
904-953-1594Principal Investigator:
Melanie P. Caserta, MD
Mayo Clinic in Rochester
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Jaydev Dave, Ph.D
Dave.Jaydev@mayo.eduPrincipal Investigator:
Jaydev K. Dave, PhD
Sponsor
Mayo Clinic
Last update posted
Aug 14, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-08-14.